Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020.
Steven J DrewsKento T AbeQueenie HuReuben SamsonAnne-Claude GingrasKaren ColwillBhavisha RathodJenny WangMahya Fazel-ZarandiQi-Long YiAlyssia RobinsonHeidi WoodAshleigh TuiteDavid FismanDavid H EvansYi-Chan J LinSheila F O'BrienPublished in: Transfusion (2021)
This preliminary data can be used as a justification for limiting the use of first wave plasma products in upcoming clinical trials but cannot be used to speculate on general trends in the immunity of Canadian blood donors to SARS-CoV-2.